The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice

被引:12
作者
Harris, SJ [1 ]
Woodrow, SA [1 ]
Gearing, AJH [1 ]
Adams, SE [1 ]
Kingsman, AJ [1 ]
Layton, GT [1 ]
机构
[1] UNIV OXFORD, DEPT BIOCHEM, VIRUS MOL BIOL GRP, OXFORD OX1 3QU, ENGLAND
关键词
adjuvants; virus-like particles; cytotoxic T-lymphocyte; HIV-1; V3;
D O I
10.1016/0264-410X(96)00010-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously described the generation of HIV-1 V3-specific cytotoxic T-lymphocytes (CTL) responses in BALB/c (H-2(d)) mice following immunization with Ty-virus-like particles carrying the V3 loop of gp120 (V3-VLPs) without adjuvant. In this study the effects of various adjuvants on CTL induction by V3-VLPs was examined Mice immunized with V3-VLPs formulated in aqueous-based adjuvants, Deter, gamma-inulin, galactosaminylmuramyl dipeptide and Chemivax generated V3-specific CTL responses, although at reduced levels when compared to the no adjuvant group. V3-VLPs prepared in Alhydrogel, algamulin or as an oil emulsion in SAF-MF failed to generate V3-specific CTL responses. The mechanism whereby alum prevented the induction of a CTL response was investigated further. Immunization with V3-VLPs prepared in non-saturating doses of alum or alum plus EDTA primed for strong CTL responses, indicating that free VLPs do, but alum-bound VLPs do not enter the MHC class I processing pathway of antigen-presenting cells (APCs). Furthermore, V3-VLPs with very low doses of alum led to an enhancement of the CTL response. The formulation of hybrid Ty-VLPs in oil based or precipitating adjuvants, therefore, inhibits access to the MHC class I processing pathway of APCs. The intact particulate structure of hybrid VLPs is therefore strictly necessary for CTL induction. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:971 / 976
页数:6
相关论文
共 28 条
[11]  
HARDING CV, 1994, J IMMUNOL, V153, P4925
[12]  
HARRIS SJ, 1992, IMMUNOLOGY, V77, P315
[13]   EFFICIENT MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PRESENTATION OF EXOGENOUS ANTIGEN UPON PHAGOCYTOSIS BY MACROPHAGES [J].
KOVACSOVICSBANKOWSKI, M ;
CLARK, K ;
BENACERRAF, B ;
ROCK, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :4942-4946
[14]   AN ACTIVATED CD8+ T-CELL PHENOTYPE CORRELATES WITH ANTI-HIV ACTIVITY AND ASYMPTOMATIC CLINICAL STATUS [J].
LANDAY, AL ;
MACKEWICZ, CE ;
LEVY, JA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 69 (01) :106-116
[15]  
LAYTON GT, 1993, J IMMUNOL, V151, P1097
[16]   VACCINATION WITH IMMUNODOMINANT PEPTIDES ENCAPSULATED IN QUIL A-CONTAINING LIPOSOMES INDUCES PEPTIDE-SPECIFIC PRIMARY CD8+ CYTOTOXIC T-CELLS [J].
LIPFORD, GB ;
WAGNER, H ;
HEEG, K .
VACCINE, 1994, 12 (01) :73-80
[17]   DENDRITIC CELLS AND MACROPHAGES ARE REQUIRED FOR TH1 DEVELOPMENT OF CD4+ T-CELLS FROM ALPHA-BETA-TCR TRANSGENIC MICE - IL-12 SUBSTITUTION FOR MACROPHAGES TO STIMULATE IFN-GAMMA PRODUCTION IS IFN-GAMMA-DEPENDENT [J].
MACATONIA, SE ;
HSIEH, CS ;
MURPHY, KM ;
OGARRA, A .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (09) :1119-1128
[18]  
MITCHELL MS, 1988, CANCER RES, V48, P5883
[19]   HUMAN TH1 AND TH2 SUBSETS - DOUBT NO MORE - COMMENT [J].
MOSMANN, T .
IMMUNOLOGY TODAY, 1991, 12 (08) :257-257
[20]   PHAGOCYTIC PROCESSING OF BACTERIAL-ANTIGENS FOR CLASS-I MHC PRESENTATION TO T-CELLS [J].
PFEIFER, JD ;
WICK, MJ ;
ROBERTS, RL ;
FINDLAY, K ;
NORMARK, SJ ;
HARDING, CV .
NATURE, 1993, 361 (6410) :359-362